13F manager/IONS/

Baillie Gifford trim Ionis Pharmaceuticals, Inc.

Baillie Gifford trim $1.6M of disclosed value in Ionis Pharmaceuticals, Inc..

Signal
Investor Move
Action
Trim
Capital
$1.6M disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence